In summary, this study demonstrated that promoter methylation of PCDH10 plays a significant role in NSCLC progression and might be a promising prognostic marker for patients with curatively resected pathological stage I NSCLC. This evidence concerns the gene PCDH10 and non-small cell lung carcinoma.